Education
About Us
Working with TipRanks
Follow Us
2cureX AB (SE:2CUREX)
:2CUREX
2CUREX Stock Chart & Stats
kr1.09
-kr0.03(-8.38%)
At close: 4:00 PM EST
kr1.09
-kr0.03(-8.38%)
Day’s Range― - ―
52-Week Rangekr0.33 - kr5.52
Previous CloseN/A
Volume2.79K
Average Volume (3M)53.14K
Market Cap
€35.14M
Enterprise ValueN/A
Total Cash (Recent Filing)€3.13M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta0.35
Next Earnings
Feb 26, 2026EPS EstimateN/A
Last Dividend Ex-Date
Jun 27, 2025Dividend Yield7.71%
Share Statistics
EPS (TTM)N/A
Shares Outstanding25,102,917
10 Day Avg. Volume69,592
30 Day Avg. Volume53,143
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)1.75
Price to Sales (P/S)0.00
P/FCF Ratio-1.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
2CUREX FAQ
What was 2cureX AB’s price range in the past 12 months?
2cureX AB lowest stock price was kr0.33 and its highest was kr5.52 in the past 12 months.
What is 2cureX AB’s market cap?
2cureX AB’s market cap is €35.14M.
When is 2cureX AB’s upcoming earnings report date?
2cureX AB’s upcoming earnings report date is Feb 26, 2026 which is in 82 days.
How were 2cureX AB’s earnings last quarter?
Currently, no data Available
Is 2cureX AB overvalued?
According to Wall Street analysts 2cureX AB’s price is currently Overvalued.
Does 2cureX AB pay dividends?
2cureX AB pays a Notavailable dividend of kr0.084 which represents an annual dividend yield of 7.71%. See more information on 2cureX AB dividends here
What is 2cureX AB’s EPS estimate?
2cureX AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does 2cureX AB have?
2cureX AB has 25,102,917 shares outstanding.
What happened to 2cureX AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of 2cureX AB?
Currently, no hedge funds are holding shares in SE:2CUREX
Company Description
2cureX AB
2cureX AB (publ) operates as a medtech company in Europe. Its principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. The company is also conducting various clinical programs for IndiTreat for breast colorectal, ovarian, and pancreatic cancers. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.
Technical Analysis
OncoZenge AB
―
LIDDS AB
―
ExpreS2ion Biotech Holding AB
―
CombiGene AB
―
Sprint Bioscience AB
―